Ambrx Biopharma, Inc.
AMAMDelisted Mar 7, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001990550
Ambrx Biopharma, Inc. was delisted on Mar 7, 2024; its insiders filed their last Form 4 on Mar 7, 2024; 68 institutions reported holding it in 13F filings for Q4 2023, worth $912.7M in total; no superinvestor held it.
13F holders, Q1 2024
Institutional positions in Ambrx Biopharma, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
AMAM is no longer listed, and 13F filings after Q4 2023 list far fewer holders. See Q4 2023
- Institutional holders
- 0
- −68 vs. Q4 2023
- Shares held
- 0
- −64.1M (−100.0%) vs. Q4 2023
- Total value
- $0
- −$912.7M (−100.0%) vs. Q4 2023
- New holders
- 0
- 0 more added
- Sold out
- 68
- 0 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AMAM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 68 | $912.7M |
| Q3 2023 | 44 | $568.3M |
| Q2 2023 | 42 | $788.8M |
| Q1 2023 | 30 | $330.7M |
| Q4 2022 | 18 | $40.7M |
| Q3 2022 | 16 | $18.0M |
| Q2 2022 | 14 | $45.4M |
| Q1 2022 | 14 | $70.6M |
| Q4 2021 | 16 | $152.0M |
| Q3 2021 | 15 | $165.3M |
| Q2 2021 | 20 | $266.2M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Ambrx Biopharma, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Darwin Global Management, Ltd. | 0 | $0 | 0.00% | −16,688,636−100.0% | Sold out |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −11,231,000−100.0% | Sold out |
| Paradigm Biocapital Advisors LP | 0 | $0 | 0.00% | −4,352,689−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −4,240,486−100.0% | Sold out |
| Deep Track Capital, LP | 0 | $0 | 0.00% | −3,710,412−100.0% | Sold out |
| Nextech Invest AG | 0 | $0 | 0.00% | −3,129,300−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −2,154,700−100.0% | Sold out |
| Logos Global Management LP | 0 | $0 | 0.00% | −2,100,000−100.0% | Sold out |
| VR Adviser, LLC | 0 | $0 | 0.00% | −2,070,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −2,042,212−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1,474,258−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −1,399,642−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −1,255,148−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −1,084,247−100.0% | Sold out |
| WuXi AppTec Co., Ltd. | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −501,604−100.0% | Sold out |
| Ghost Tree Capital, LLC | 0 | $0 | 0.00% | −475,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −432,709−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −399,648−100.0% | Sold out |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −385,383−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −330,949−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −296,000−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −295,642−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −263,743−100.0% | Sold out |
| Alliancebernstein L.P. | 0 | $0 | 0.00% | −258,364−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −207,500−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −203,122−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −199,950−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −140,842−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −140,256−100.0% | Sold out |
| StemPoint Capital LP | 0 | $0 | 0.00% | −126,101−100.0% | Sold out |
| Lighthouse Investment Partners, LLC | 0 | $0 | 0.00% | −88,925−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −87,678−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −81,157−100.0% | Sold out |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −78,811−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −77,472−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −70,094−100.0% | Sold out |
| Connective Capital Management, LLC | 0 | $0 | 0.00% | −58,189−100.0% | Sold out |
| HealthInvest Partners AB | 0 | $0 | 0.00% | −57,847−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −53,900−100.0% | Sold out |
| Nwi Management LP | 0 | $0 | 0.00% | −53,645−100.0% | Sold out |
| Saturn V Capital Management LLC | 0 | $0 | 0.00% | −52,781−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −50,015−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −49,203−100.0% | Sold out |
| Altitude Crest Partners Inc. | 0 | $0 | 0.00% | −43,100−100.0% | Sold out |
| Sierra Summit Advisors LLC | 0 | $0 | 0.00% | −37,237−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −36,733−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −32,886−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −25,276−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −20,386−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −18,774−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −15,804−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −15,470−100.0% | Sold out |
| Old Well Partners, LLC | 0 | $0 | 0.00% | −14,400−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −12,388−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −12,312−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −10,800−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −10,040−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −7,657−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −7,303−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −6,878−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −5,614−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −3,840−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −2,380−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −491−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −906−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −258−100.0% | Sold out |